Fund Holdings — GordonMD Global Investments LP

Total Portfolio Value:
$166.47M
Total Bought:
$166.47M
Total Sold:
$0
Net Transaction:
+$166.47M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Pyxis Oncology Inc015,541,909+15,541,909$0$36.21M21.75%+$36.21M
Kyverna Therapeutics Inc04,521,318+4,521,318$0$30.74M18.47%+$30.74M
Teva Pharmaceutical Inds LtdSHS0379,520+379,520$0$15.03M9.03%+$15.03M
Celldex Therapeutics, Inc.(CLDX)0279,720+279,720$0$9.07M5.45%+$9.07M
Tango Therapeutics, Inc.(TNGX)01,852,495+1,852,495$0$9.02M5.42%+$9.02M
Vir Biotechnology, Inc.(VIR)0803,552+803,552$0$8.98M5.40%+$8.98M
Adarx Pharmaceuticals Inc0450,000+450,000$0$8.97M5.39%+$8.97M
Allogene Therapeutics Inc05,298,000+5,298,000$0$8.48M5.09%+$8.48M
Bausch Plus Lomb Corp0475,472+475,472$0$8.08M4.86%+$8.08M
Editas Medicine Inc03,127,000+3,127,000$0$8.04M4.83%+$8.04M
Incyte Corporation(INCY)051,080+51,080$0$6.20M3.72%+$6.20M
Taysha Gene Therapies, Inc.(TSHA)0248,000+248,000$0$6.19M3.72%+$6.19M
Amgen Inc.(AMGN)014,512+14,512$0$6.12M3.67%+$6.12M
Scholar Rock Holding Corporation(SRRK)0110,500+110,500$0$5.34M3.21%+$5.34M
Page 1 of 1